Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa

Summary

To assess whether intravenously administered third-party bone marrow-derived mesenchymal stromal cells (MSCs) are safe and have an impact on disease severity in RDEB

Timeline

Start

2015-06

Primary completion

2017-07

Completion

2017-07

Drugs

Indications